InvestorsObserver is giving Genmab A/S - ADR (GMAB) an Analyst Rating Rank of 21, meaning GMAB is ranked higher by analysts than 21% of stocks. The average price target for GMAB is $37.757 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating GMAB a Buy today. Find out what this means to you and get the rest of the rankings on GMAB!
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With Genmab A/S - ADR Stock Today?
Genmab A/S - ADR (GMAB) stock is trading at $30.86 as of 10:22 AM on Tuesday, May 24, a rise of $0.03, or 0.1% from the previous closing price of $30.83. The stock has traded between $30.77 and $31.13 so far today. Volume today is less active than usual. So far 65,318 shares have traded compared to average volume of 791,152 shares.
Click Here to get the full Stock Report for Genmab A/S - ADR stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
